Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study finds climate hazards can aggravate over half of known human infectious diseases

A recent article posted to the journal Nature Climate Change demonstrated that climate change could aggravate about 50% of recognized human pathogenic illnesses.

10 Aug 2022

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say scientists. The warning comes following the results of a new study, published in The Lancet Regional Health - Europe, which found that over 55% of respiratory disease hospitalizations during the pandemic's peak were caused by non-SARS-CoV-2 infections.

10 Aug 2022

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Researchers described the development and applications of a 3D-printed lab-on-a-chip device that quickly detected the presence of SARS-CoV-2 in patient's saliva.

10 Aug 2022

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

Recently, 'Long COVID' is becoming a significant issue worldwide. It refers to a variety of symptoms that persist over an extended period after the patient has recovered from a novel coronavirus infection (COVID-19). In many cases, it is unclear what causes Long COVID symptoms, and there is insufficient information regarding recovery time.

10 Aug 2022

A broad sarbecovirus-neutralizing antibody cocktail

Researchers present a rational approach for identifying SARS-CoV-2 receptor-binding domain-targeted broad neutralizing antibody cocktails.

9 Aug 2022

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Researchers assess the sensitivity of the SARS-CoV-2 Omicron BA.2.75 sublineage to neutralization.

9 Aug 2022

Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

Researchers estimate the proportion of Icelandic residents reinfected with the SARS-CoV-2 Omicron variant.

9 Aug 2022

Lower risk of MIS-C during Omicron wave

Researchers estimate the risk of multisystem inflammatory syndrome in children (MIS-C) in Denmark.

9 Aug 2022

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

Researchers assess the impact of extending the interval between primary and booster COVID-19 vaccine doses.

9 Aug 2022

Does loneliness affect the brain and heart?

Scientists review studies to determine the effects of social isolation and loneliness on brain health and cardiovascular conditions.

9 Aug 2022

New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

Just as with COVID-19, future viral outbreaks will have plenty of time to spread before a vaccine becomes available. A new approach developed at NTNU can save lives and prevent the need to shut down society.

9 Aug 2022

SARS-CoV-2 infection in mothers does not have a significant teratogenic effect

Scientists determine that infection with SARS-CoV-2 during the first trimester of pregnancy does not increase the risk of any specific congenital malformations.

9 Aug 2022

Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

Researchers evaluated the impact of double BNT162b2 messenger ribonucleic acid (mRNA) vaccination in recognition of SARS-CoV-2 variants of concern.

9 Aug 2022

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

Researchers explored the recovery rate and prevalence of the COVID-19-associated taste and smell impairments after two years across patients with mild symptoms.

9 Aug 2022

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.

9 Aug 2022

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

Scientists analyzed the differences between SARS-CoV-2 rebound associated with the Omicron BA.2.12.1 and BA.5 sublineages post-Paxlovid therapy in the United States.

9 Aug 2022

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Researchers demonstrated differential utilization of the B cell germlines and SARS-CoV-2 spike protein epitopes by cross-neutralizing antibodies in infected, vaccinated and individuals with hybrid immunity.

9 Aug 2022

Post-COVID-19 symptoms may occur in one of eight SARS-CoV-2-infected individuals

In a new study, researchers analyzed the nature, incidence, and severity of 23 COVID-19-related persistent symptoms in the Netherlands.

9 Aug 2022

Covid sewage surveillance labs join the hunt for monkeypox

The same wastewater surveillance techniques that have emerged as a critical tool in early detection of covid-19 outbreaks are being adapted for use in monitoring the startling spread of monkeypox across the San Francisco Bay Area and some other U.S. communities.

9 Aug 2022

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Scientists explored the influence of SARS-CoV-2 extended gap vaccination on the variants of concern neutralization.

9 Aug 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Study finds climate hazards can aggravate over half of known human infectious diseases

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

A broad sarbecovirus-neutralizing antibody cocktail

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Icelandic study suggests SARS-CoV-2 Omicron reinfection more common than previously thought

Lower risk of MIS-C during Omicron wave

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

Does loneliness affect the brain and heart?

New approach for developing antiviral drugs could slow down future viral outbreaks, save lives

SARS-CoV-2 infection in mothers does not have a significant teratogenic effect

Double mRNA COVID-19 vaccination found to increase SARS-CoV-2 variant recognition

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

Study details post-COVID-19 symptoms and conditions among children and adolescents in the US

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Post-COVID-19 symptoms may occur in one of eight SARS-CoV-2-infected individuals

Covid sewage surveillance labs join the hunt for monkeypox

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in